RIGL Rigel Pharmaceuticals Inc: Earnings per share for the last twelve months
Rigel Pharmaceuticals (RIGL) maintains its stock price momentum through its authority in treating plasma cell diseases. However, patent dependency and testing costs hinder profitability, although a focus on narrow hematology niches protects margins. The rolling profit per share history demonstrates effective capital management, and the 15.61 mark shows the current state of this fundamental indicator.
Analytical breakdowns and data insights for company Rigel Pharma (RIGL)
- current quotes and average value forecast:
- company stock capitalization data:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Rigel Pharmaceuticals|RIGL - Long-Term Liabilities to Capital|Short-Term Debt to Equity Rigel Pharmaceuticals Inc|RIGL - Aggregate Debt Obligations|Debts to Book Capitalization Rigel Pharmaceuticals, Inc.|RIGL - Long-Term Debt Volume|Company Short-Term Debts Rigel Pharmaceuticals|Quick Ratio rigel.com
- earnings and valuation multiples indicators:
RIGL - Company Net Income|Expected Profit Rigel Pharmaceuticals|RIGL - Price to Earnings Ratio|Projected Price to Earnings Rigel Pharmaceuticals, Inc.|RIGL - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Rigel Pharmaceuticals, Inc.|RIGL - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share (EPS TTM) Rigel Pharmaceuticals|RIGL - Earnings per share for the trailing year|Quarterly EPS earnings growth rigel.com|RIGL - Earnings growth in current year|Net earnings per share growth forecast for next year Rigel Pharmaceuticals
- sales and revenue data:
General company analysis:Rigel Pharmaceuticals (RIGL)
Net income per share (TTM) measures the final return on each unit of equity over a year, excluding distortions caused by changes in the volume of issuance. By analyzing the TTM earnings per share metric, an investor assesses the cost management efficiency of Rigel Pharmaceuticals (RIGL), where the outsourcing of production and distribution allows for the optimization of capital expenditures to stabilize earnings per share.
Competitors of Rigel Pharmaceuticals
ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|Abivax Pharma (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics Inc|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) Immunovant Therapeutics|Earnings per share for the last twelve months Kiniksa Pharmaceuticals (KNSA)|grifols.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (Adaptive Biotechnologies Corporation)|Celldex Therapeutics Inc (CLDX) - Net earnings per one share for the last twelve months|AUPH - Earnings per share for the last twelve months|Earnings per share for the trailing year BCRX (BioCryst Corp)|VERA: Net earnings per share (EPS TTM)|DNTH - Net earnings per share for the last four quarters|PHVS (Pharvaris) - Net earnings per share (EPS TTM)|ABCL - Net earnings per share for the trailing year|Net earnings per share (EPS TTM) TRML|PGEN - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Pharming Group N.V. PHAR|nektar.com - Earnings per share for the last twelve months|UPB: Net earnings per share for the last 12 months|Earnings per share for the trailing year ZBIO (Zenas Bio)|Immunome Corp (IMNM) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months GOSS (Gossamer Bio Corp.)|KALV (KalVista Pharmaceuticals) - Net earnings per share (EPS TTM)|SEPN: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PVLA|Net earnings per share (EPS TTM) Savara Inc (SVRA)|Earnings per share for the last twelve months AnaptysBio Corp ANAB|Earnings per share for the trailing year ATXS|ENGN - Earnings per share for the last twelve months|RAPT Therapeutics Inc. (RAPT) - Net earnings per share for the last 12 months|JBIO: Net earnings per share (EPS TTM)|Aclaris Therapeutics Inc. (ACRS) - Net earnings per share (EPS TTM)|KYTX (Kyverna) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Tiziana Life Sciences, Ltd. (TLSA)|Net earnings per share (EPS TTM) CABA|VTYX - Net earnings per one share for the last twelve months|Theratechnologies - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Avalo Therapeutics, Inc. AVTX|ELDN: Net earnings per share for the last 12 months|Agenus, Inc - Earnings per share for the last four quarters|CLYM: Net earnings per share (EPS TTM)|ZURA - Net earnings per share for the last four quarters|ATYR (aTyr Pharma) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Adagene Corp (ADAG)|Net earnings per share (EPS TTM) IMA|Net earnings per share (EPS TTM) shattucklabs.com (STTK)|Earnings per share for the last twelve months Equillium EQ|Connect Biopharma Holdings - Earnings per share for the last twelve months|IMUX - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Atara Biotherapeutics ATRA|inflarx.de (IFRX) - Earnings per share for the last twelve months|X4 Pharmaceuticals, Inc - Earnings per share for the trailing year|ACET (Adicet Bio Inc.) - Net earnings per share (EPS TTM)|Celularity Corp (CELU) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) INMB|Barinthus Biotherapeutics PLC (BRNS) - Net earnings per share for the trailing year|Earnings per share for the last twelve months Kezar Life Sciences, Inc KZR|SAB Biotherapeutics Inc - Earnings per share for the last twelve months|AKTX - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ENLV|QTTB: Net earnings per share (EPS TTM)|GeoVax Labs - Earnings per share for the trailing year|EDSA (Edesa) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) iBio Corporation|Earnings per share for the last twelve months Carisma Therapeutics (CARM)|XTLB (xtlbio.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Bolt Biotherapeutics, Inc. BOLT|HCWB - Net earnings per share for the last 12 months|Aptevo - Net earnings per share (EPS TTM)|AIM - Net earnings per share (EPS TTM)|ADTX (aditxt.com) - Net earnings per share for the last 12 months|gribio.com - Earnings per share for the trailing year|XRTX (XORTX Therapeutics) - Net earnings per share (EPS TTM)|Vyome Holdings Inc. (HIND) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Revelation Bio (REVB)|Net earnings per share for the last 12 months Indaptus Corp INDP|Earnings per share for the last twelve months Scinai Immunotherapeutics SCNI|CALI - Net earnings per share for the last 12 months|AFMD: Net earnings per share for the last 12 months|ALLK - Net earnings per share (EPS TTM)|hookipapharma.com (HOOK) - Earnings per share for the last twelve months|Earnings per share for the last 12 months IGMS|ITOS (iTeos Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months oceanbiomedical.com OCEA|Earnings per share for the last twelve months TC BioPharm (TCBP)|THRD (Third Harmonic Bio Inc.) - Earnings per share for the trailing year
